Mechanism of photofrin-enhanced ultrasound-induced human glioma cell death

Anticancer Research

Volumn 29, Issue 3, 2009, Pages 897-906

  Hayashi, Shuji ^a   Yamamoto, Masaki ^a   Tachibana, Katsuhiro ^a   Ueno, Yushi ^a   Bu, Guojun ^b   Fukushima, Takeo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glioma; LRP a2MR; Photofrin; U105MG; U251MG; Ultrasound

Indexed keywords

CELL SURFACE RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PHOTOFRIN; PHOTOSENSITIZING AGENT; PROTEIN DERIVATIVE; RECEPTOR ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CELL DEATH; CELL KILLING; CELL STRAIN U105MG; CELL STRAIN U251MG; CONFERENCE PAPER; DRUG EFFICACY; ECHOGRAPHY; GLIOMA; LOW LEVEL LASER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT DURATION; TUMOR CELL;

ALPHA-MACROGLOBULINS; BRAIN NEOPLASMS; CELL SURVIVAL; COMBINED MODALITY THERAPY; DIHEMATOPORPHYRIN ETHER; GLIOMA; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; PHOTOSENSITIZING AGENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; ULTRASONIC THERAPY;

EID: 64949156962     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (53)

1. Russel DC and Rubinstain LJ: Pathology of Tumors of the Nervous System. London: Edward Arnold, 1989.
2. Subach BR, Witham TF, Kondziolka D, Lunsford LD, Bozik M and Schiff D: Morbidity and survival after 1,3-bis(2-chloroethyl)-l-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series. Neurosurgery 45(1): 17-22, 1999.
3. Kleinberg LR, Weingart J, Burger P, Carson K, Grossman SA, Li K, Olivi A, Wharam MD and Brem H: Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management. Cancer Invest 22(1): 1-9, 2004.
4. Larson DA, Suplica JM, Chang SM, Lamborn KR, McDermott MW, Sneed PK, Prados MD, Wara WM, Nicholas MK and Berger MS: Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neurooncol 6(2): 119-126,2004.
5. Fiveash JB and Spencer SA: Role of radiation therapy and radiosurgery in glioblastoma multiforme. Cancer J 9(3): 222-229, 2003.
6. Black PM, Schoene WC and Lampson LA: Astrocytomas: Diagnosis, Treatment, and Biology. Boston: Blackwell Scientific Publications, 1993.
7. Burton EC and Prados MD: Malignant gliomas. Curr Treat Options Oncol 1(5): 459-468, 2000.
8. Eljamel MS: New light on the brain: The role of photosensitizing agents and laser light in the management of invasive intracranial tumors. Technol Cancer Res Treat 2(4): 303-309, 2003.
9. Origitano TC, Karesh SM, Henkin RE, Halama JR and Reichman OH: Photodynamic therapy for intracranial neoplasms: investigations of photosensitizer uptake and distribution using indium-111 Photofrin-II single photon emission computed tomography scans in humans with intracranial neoplasms. Neurosurgery 32(3): 357-363, 1993.
10. Kaye AH and Morstyn G: Photoradiation therapy causing selective tumor kill in a rat glioma model. Neurosurgery 20(3): 408-415, 1987.
11. Hill JS, Kahl SB, Stylli SS, Nakamura Y, Koo MS and Kaye AH: Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer. Proc Natl Acad Sci USA 92(26): 12126-12130, 1995.
12. Cheng MK, McKean J, Boisvert D, Tulip J and Mielke BW: Effects of photoradiation therapy on normal rat brain. Neurosurgery 75(6): 804-810, 1984.
13. Chapelon JY, Margonari J, Vernier F, Gorry F, Ecochard R and Gelet A: In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327. Cancer Res 52(22): 6353- 6357,1992.
14. Hill CR and ter Haar GR: Review article: high intensity focused ultrasound-potential for cancer treatment. Br J Radiol 68(816): 1296-1303, 1995.
15. Tachibana K, Uchida T, Hisano S and Morioka E: Eliminating adult T-cell leukaemia cells with ultrasound. Lancet 349(9048): 325,1997.
16. Tachibana K, Uchida T, Ogawa K, Yamashita N and Tamura K: Induction of cell membrane porosity by ultrasound. Lancet 353(9162): 1409, 1999.
17. Feril LB Jr, Kondo T, Zhao QL, Ogawa R, Tachibana K, Kudo N, Fujimoto S and Nakamura S: Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med Biol 29(2): 331-337, 2003.
18. Ritz R, Wein HT, Dietz K, Schenk M, Roser F, Tataqiba M and Strauss WS: Photodynamic therapy of malignant with hypericin: comprehensive in vitro study in human glioblastoma cell lines. Int J Oncol 30(3): 659-667, 2007.
19. Lagneaux L, de Meulenaer EC, Delforge A, Dejeneffe M, Massy M, Moerman C, Hannecart B, Canivet Y, Lepeltier MF and Bron D: Ultrasonic low-energy treatment: a novel approach to induce apoptosis in human leukemic cells. Exp Hematol 30(11): 1293-1301,2002.
20. Honda H and Zhao QL: Kondo T. Effects of dissolved gases and an echo-contrast agent on apoptosis induced by ultrasound and its mechanism via the mitochondria-caspase pathway. Ultrasound Med Biol 28(5): 673-682, 2002.
21. ter Haar G, Rivens I, Chen L and Riddler S: High intensity focused ultrasound for the treatment of rat tumours. Phys Med Biol 36(11): 1495-1501, 1991.
22. Lobel J, MacDonald IJ, Ciesielski MJ, Barone T, Potter WR, Pollina J, Plunkett RJ, Fenstermaker RA and Dougherty TJ: 2-[l-Hexyloxyethyl]-2-devinyl pyropheophorbide-a(HPPH)in a nude rat glioma model: implications for photodynamic therapy. Lasers Surg Med 29(5): 397-405, 2001.
23. Jori G and Reddi E: The role of lipoproteins in the delivery of tumour-targeting photosensitizers. Int J Biochem 25(10): 1369- 1375,1993.
24. Maziere JC, Morliere P and Santus R: The role of the low- density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours. J Photochem Photobiol B 8(4): 351-360, 1991.
25. Luna MC, Ferrario A, Rucker N and Gomer CJ: Decreased expression and function of alpha-2 macroglobulin receptor/low- density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumor cells. Cancer Res 55(9): 1820- 1823,1995.
26. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H and Stanley KK: Surface location and high affinity for calcium of a 500-kDa liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 7(13): 4119-4127, 1988.
27. Yamamoto M, Ikeda K, Ohshima K, Tsugu H, Kimura H and Tomonaga M: Increased expression of low-density lipoprotein receptor-related protein/α2-macroglobulin receptor in human malignant astrocytomas. Cancer Res 57: 2799-2805, 1977.
28. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL and Rao JS: Differential expression of membrane-type matrix metallo-proteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56(2): 384-392, 1996.
29. Bu G, Maksymovitch EA, Geuze H and Schwartz AL: Subcellular localization and endocytic function of low-density lipoprotein receptor-related protein in human glioblastoma cells. J Biol Chem 269: 29874-29882, 1994.
30. Herz J, Clouthier DE and Hammer RE: LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 71: 411-421, 1992.
31. Strickland DK, Kounnas MZ, Williams SE and Argraves WS: LDL receptor-related protein(LRP): a multiligand receptor. Fibrinolysis 8(Suppl 1): 204-215, 1994.
32. Kowal RC, Herz J, Goldstein JL, Esser V and Brown MS: Low-density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E- enriched lipoproteins. Proc Natl Acad Sci USA 86: 5810-5814, 1989.
33. Kounnas MZ, Morris RE, Thompson MR, FitzGerald DJ, Strickland DW and Saelinger CB: The α2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J Biol Chem 267: 12420-12423, 1992.
34. Strickland DK, Ashcom JD, Williams S, Battery F, Behre E, McTigre K, Battey JF and Arqraves WS: Primary structure of alpha 2-macroglobulin receptor-associated protein. J Biol Chem 266: 13364-13369, 1991.
35. Bu G, Williams S, Strickland DK and Schwartz AL: Low-density lipoprotein receptor-related protein/α2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proc Natl Acad Sci USA 89: 7427-7431, 1992.
36. Nykjaer A, Peterson CM, Moller B, Jensen PH, Moestrup SK, Holtet TL, Etzerodt M, Thoqersen HC, Munch M and Andreasen PA: Purified a2-macroglobulin receptor/LDL receptor-related protein binds urokinase-plasminogen activator inhibitor type-1 complex. Evidence that the α2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J Biol Chem 267: 14543-14546, 1992.
37. Moestrup SK, Gliemann J and Pallesen G: Distribution of the α2-macroglobulin receptor/low-density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 269: 375-382, 1992.
38. Saksela O, Wahstrom T, Lehtowirta P, Markku S and Vaheri A: Presence of a2-macroglobulin in normal but not in malignant synctiotrophoblasts. Cancer Res 41: 2507-2513, 1981.
39. Van Leuven F, Cassiman J-J and Van den Berghe H: Demonstration of an ce2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines. J Biol Chem 254: 5155-5160, 1979.
40. Kaye AH and Hill JS: Photodynamic therapy of brain tumours. Ann Acad Med Singapore 22(3 Suppl): 470-481, 1993.
41. Kennedy JC and Pottier RH: Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14(4): 275-292, 1992.
42. Yu T, Wang Z and Mason TJ: A review of research into the uses of low level ultrasound in cancer therapy. Ultrason Sonochem 11(2): 95-103,2004.
43. Umemura S, Yumita N, Nishigaki R and Umemura K: Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res 81(9): 962-966, 1990.
44. Ashush H, Rozenszajn LA, Blass M, Barda-Saad M, Azimov D, Radnay J, Zipori D and Rosenschein U: Apoptosis induction of human myeloid leukemic cells by ultrasound exposure. Cancer Res 60(4): 1014-1020, 2000.
45. Carstensen EL, Kelly P, Church CC, Brayman AA, Child SZ, Raeman CH and Schery L: Lysis of erythrocytes by exposure to CW ultrasound. Ultrasound Med Biol 19(2): 147-165, 1993.
46. Feigl T, Volklein B, Iro H, Ell C and Schneider T: Biophysical effects of high-energy pulsed ultrasound on human cells. Ultrasound Med Biol 22(9): 1267-1275, 1996.
47. Miller MW, Miller DL and Brayman AA: A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol 22(9): 1131-1154, 1996.
48. Evensen JF, Sommer S, Moan J and Christensen T: Tumor- localizing and photosensitizing properties of the main components of hematoporphyrin derivative. Cancer Res 44(2): 482-486, 1984.
49. Thomas JP, Hall RD and Girotti AW: Singlet oxygen intermediacy in the photodynamic action of membrane-bound hematoporphyrin derivative. Cancer Lett 35(3): 295-302, 1987.
50. Gleave JR: Surgery for primary brain tumors. In: Tumors of the Brain. Blehen NM(ed.). Berlin: Springer Verlag, pp. 101-120, 1986.
51. Yamamoto M, Ueno Y, Hayashi S and Fukushima T: The role of proteolysis in tumor invasiveness in glioblastoma and metastatic brain tumors. Anticancer Res 22(6C): 4265-4268, 2002.
52. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lanq FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D and Sawaya R: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95(2): 190-198, 2001.
53. Yamamoto M, Oka K, Takasugi S, Hachisuka S, Miyake E and Tomonaga M: Flexible neuroendoscopy for percutaneous treatment of intraventricular lesions in the absence of hydrocephalus. Minim Invasive Neurosurg 40(4): 139-143, 1997.